Literature DB >> 29136564

Frustration stress (unexpected loss of alternative reinforcement) increases opioid self-administration in a model of recovery.

Brett C Ginsburg1, R J Lamb2.   

Abstract

PURPOSE: Engaging in alternative activities in the context where opioid use had occurred can constrain opioid use and helps to maintain recovery. However, "frustration stress" that occurs when contingencies on these alternative activities unexpectedly change (e.g., job loss or divorce) is thought to threaten recovery by prompting a return to drug use. Yet it remains unclear whether frustration stress can result in a return to drug use, and if so, whether it returns to prior levels or to even greater levels. PROCEDURES: We examine the impact of unsignaled extinction of alternative reinforcement on opioid use. Rats were trained to respond for an etonitazene solution (5μg/ml, p.o.), then for food in alternating daily sessions. Subsequently, food and etonitazene were made concurrently available. Under concurrent availability conditions, rats were exposed to 1, 2, or 4 sessions of unsignaled food extinction, and effects on responding for etonitazene and food measured.
FINDINGS: When etonitazene was the only reinforcer available, rats earned 58.3±20.3μg/kg/session (mean±S.E.M.). When food was available in alternating sessions, etonitazene earned was unchanged (65.3±19.2μg/kg/session). Concurrent food availability decreased etonitazene earned (13.5±4.5μg/kg/session). Unsignaled food extinction returned etonitazene earnedto levels similar to (60.5±18.4μg/kg/session), but not greater than, those observed previously when etonitazene alone was available.
CONCLUSIONS: Unsignaled extinction of alternative behavior controlling opioid use can result in increased opioid use, but this use does not rise beyond previous levels observed when opioid use is unconstrained by alternative reinforced behavior.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Habit; Heroin; Oxycodone; Relapse

Mesh:

Substances:

Year:  2017        PMID: 29136564     DOI: 10.1016/j.drugalcdep.2017.09.016

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  7 in total

Review 1.  Measurement of substance-free reinforcement in addiction: A systematic review.

Authors:  Samuel F Acuff; Ashley A Dennhardt; Christopher J Correia; James G Murphy
Journal:  Clin Psychol Rev       Date:  2019-04-05

2.  Behavioral economics of substance use: Understanding and reducing harmful use during the COVID-19 pandemic.

Authors:  Samuel F Acuff; Jalie A Tucker; James G Murphy
Journal:  Exp Clin Psychopharmacol       Date:  2020-11-09       Impact factor: 3.157

3.  Lever-press duration as a measure of frustration in sucrose and drug reinforcement.

Authors:  Tileena E S Vasquez; Ryan J McAuley; Nikita S Gupta; Shyny Koshy; Yorkiris Marmol-Contreras; Thomas A Green
Journal:  Psychopharmacology (Berl)       Date:  2021-01-09       Impact factor: 4.530

4.  Paradoxical changes in brain reward status during oxycodone self-administration in a novel test of the negative reinforcement hypothesis.

Authors:  Jacques D Nguyen; Yanabel Grant; Michael A Taffe
Journal:  Br J Pharmacol       Date:  2021-06-08       Impact factor: 9.473

5.  Alcohol use disorder symptoms are associated with greater relative value ascribed to alcohol, but not greater discounting of costs imposed on alcohol.

Authors:  Lee Hogarth; Lorna Hardy
Journal:  Psychopharmacology (Berl)       Date:  2018-05-09       Impact factor: 4.530

Review 6.  Retrieval-Extinction and Relapse Prevention: Rewriting Maladaptive Drug Memories?

Authors:  Eloise J Kuijer; Antonio Ferragud; Amy L Milton
Journal:  Front Behav Neurosci       Date:  2020-02-20       Impact factor: 3.558

7.  Individual Differences in Frustrative Nonreward Behavior for Sucrose in Rats Predict Motivation for Fentanyl under Progressive Ratio.

Authors:  Tileena E S Vasquez; Poonam Shah; Jessica Di Re; Fernanda Laezza; Thomas A Green
Journal:  eNeuro       Date:  2021-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.